+987.9%
MRNA vs BR
-14.2%
+1,002.2%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | BR | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | +3.0% | +10.1% | +11.1% |
| 7D | +20.6% | +7.0% | +13.7% | +15.7% |
| 30D | +27.1% | +19.0% | +8.2% | +11.6% |
| 3M | +353.4% | +13.1% | +340.3% | +320.3% |
| 6M | +446.3% | +24.6% | +421.6% | +410.2% |
| YTD | +776.2% | -13.6% | +789.8% | +685.5% |
| 1Y | +987.9% | -13.1% | +1,001.0% | +879.8% |
| All | +987.9% | -14.2% | +1,002.2% | +879.8% |
Cumulative growth
Daily Returns
Daily percentage return beside BR.
Daily Out/Under-Performance
Portfolio return minus BR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded BR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling